Frontier Medicines to Present at the 43rd Annual J.P. Morgan Healthcare Conference
Frontier Medicines Corporation ("Frontier" or the "Company"), a clinical-stage precision medicine company unlocking to advance transformational therapies, today announced that Chris Varma, Ph.D., Frontier's co-founder,
Dark Matter experiment is a large research effort involving over 200 scientists and engineers at 40 institutions worldwide.
So, the WSU researchers put some xenon difluoride inside a diamond anvil and cranked the pressure up to a million atmospheres. What happened next was really cool. The molecules of the xenon ...
It has been about a month since the last earnings report for Xenon Pharmaceuticals (XENE). Shares have added about 2.4% in that time frame, outperforming the S&P 500. Will the recent positive ...
Xenon's discovery concluded an intense period of research on noble gases. Much heavier than neon and krypton, it had not been explicitly predicted, and was sufficiently rare to avoid chance ...
Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter Xenon Pharmaceuticals has unveiled promising long-term data from its X-TOLE study, showing that its drug ...
International Isotopes Inc. (OTCQB: INIS) ("International Isotopes," "INIS" or the "Company") is pleased to announce that it ...
The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...
Discover top-rated stocks from highly ranked analysts with Analyst Top Stocks! Easily identify outperforming stocks and invest smarter with Top Smart Score Stocks ...
Xenon Pharmaceuticals Inc., a neuroscience-focused biopharmaceutical company dedicated to discovering, developing, and delivering life-changing therapeutics for patients in need, announced new ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback